CFS Investment Advisory Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.46M Sell
9,251
-122
-1% -$41.8K 0.23% 85
2026
Q1
$3.33M Buy
9,373
+138
+1% +$49.2K 0.23% 83
2025
Q4
$3.02M Buy
9,235
+206
+2% +$65.3K 0.22% 90
2025
Q3
$2.63M Buy
9,029
+166
+2% +$48.1K 0.2% 100
2025
Q2
$2.48M Sell
8,863
-80
-0.9% -$22.7K 0.2% 94
2025
Q1
$2.79M Buy
8,943
+197
+2% +$58.2K 0.25% 84
2024
Q4
$2.28M Sell
8,746
-53
-0.6% -$15.7K 0.2% 93
2024
Q3
$2.83M Buy
+8,799
New +$2.88M 0.24% 80
2024
Q2
Sell
-8,975
Closed -$2.55M 267
2024
Q1
$2.55M Sell
8,975
-52
-0.6% -$15.2K 0.43% 42
2023
Q4
$2.6M Sell
9,027
-29
-0.3% -$7.9K 0.47% 38
2023
Q3
$2.43M Buy
+9,056
New +$2.26M 0.39% 51
2022
Q3
Sell
-5,268
Closed -$1.28M 238
2022
Q2
$1.28M Sell
5,268
-1,266,705
-100% -$310M 0.2% 107
2022
Q1
$5K Buy
1,271,973
+1,266,712
+24,077% +$291M 0.02% 197
2021
Q4
$1.2M Buy
5,261
+4,001
+318% +$844K 0.16% 126
2021
Q3
$268K Buy
+1,260
New +$290K 0.04% 183

Other funds holding AMGN

CFS Investment Advisory Services's AMGN Position: Q2 2026 in Review

CFS Investment Advisory Services reduced its Amgen (AMGN) stake by 1.3% in Q2 2026, selling an estimated $41.8K and leaving 9,251 shares worth $3.46M. The position accounts for 0.23% of the portfolio, ranked #85.

CFS Investment Advisory Services first reported a position in AMGN in Q3 2021 and has held it in 15 quarters since. 1,324 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • CFS Investment Advisory Services held 9,251 shares of Amgen worth $3.46M as of Q2 2026.
  • CFS Investment Advisory Services sold 122 Amgen shares in Q2 2026, an estimated $41.8K.
  • Amgen made up 0.23% of CFS Investment Advisory Services's portfolio in Q2 2026, its #85 holding.
  • CFS Investment Advisory Services first reported a position in Amgen in Q3 2021 and has held it in 15 quarters since.
  • 1,324 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on CFS Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.